Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)

Completed

Plain-English translation of NCT03180619 on ClinicalTrials.gov ↗ · Source last updated September 2021 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(30 sites)

United States

Coalition of Inclusive Medicine, Los Angeles, California

Silicon Valley Research Institute, Inc, San Jose, California

Henry Ford Health System, Detroit, Michigan

Harborview Medical Center, Seattle, Washington

Canada

University of Calgary Liver Unit, Calgary